• Brooke J Olson BS

  • Project Manager


    • Integrated Research and Development Laboratory
    • 1000 North Oak Ave. 2R3 Marshfield, WI 54449
    • (715) 221-7283

Education


2006:
BS, Major: Applied Science - Scientific Laboratory Management; Minor Chemistry, University of Wisconsin - Stout, Menomonie

Work Experience


2018 to Present:
Project Manager, Marshfield Clinic Research Institute, Marshfield
2013 to 2018:
Senior Research Associate - Integrated Research and Development Laboratory (IRDL), Marshfield Clinic Research Institute, Marshfield
2008 to 2013:
Research Associate - Integrated Research and Development Laboratory (IRDL), Marshfield Clinic Research Foundation, Marshfield
2007 to 2008:
Research Associate - Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield
2006 to 2007:
Laboratory Technician - Environmental, AgSource Cooperative Services, Stratford
2004 to 2006:
Student Laboratory Assistant - Water Testing Laboratory, University of Wisconsin - Stout, Menomonie

Professional Societies


American Society for Microbiology

Presentations


2011:
Evaluation of automated microbiology identification systems: comparison of the Sensititre Aris® and Vitek® 2 when testing Gram-positive and -negative pathogens, ECCMID
2011:
Evaluation of the Sensititre Aris® 2X and Vitek® 2 Automated Systems for Antimicrobial Susceptibility Testing of Contemporary Gram-negative Pathogens Originating from Veterinary Sources , ASM
2011:
Evaluation of the Sensititre Aris® 2X, Vitek® 2 and Phoenix® Systems for Antimicrobial Susceptibility Testing of Gram-Positive Pathogens Originating from a Regional Healthcare Network, ASM
2011:
Evaluation of the Sensititre Aris® and Vitek® 2 Automated Systems for Identification of Bacterial Pathogens Recovered from Veterinary Specimens , ASM
2011:
Evaluation of the Sensititre Aris® 2X and Vitek® 2 Automated Systems for Antimicrobial Susceptibility Testing of Staphylococci and Enterococci Originating from Veterinary Sources, ASM
2011:
Evaluation of Antimicrobial Susceptibility Test Platforms: Comparison of the Sensititre Aris® 2X, Phoenix® and Vitek® 2 When Testing Contemporary Gram-negative Bacilli, ICAAC
2012:
Application of MALDI-TOF mass spectrometry for rapid pathogen identification in an Era of ‘One Medicine-One Health’ microbiology , ECCMID
2012:
Comparison of the MALDI BioTyper™ with the Vitek ®2 and ARIS® Automated Bacterial Identification Systems: Results from a US Regional Laboratory Practice, ASM
2012:
Validation of MALDI-TOF Mass Spectrometry for Routine Bacterial Identification in a Regional Veterinary Laboratory Practice and Comparison with Automated Identification Systems , ASM
2013:
Performance Characteristics of Mass Spectrometry for the Rapid Identification of Cultured Bacterial Pathogens: Potential for Improving Laboratory Reporting in Patients Receiving Bacterially-Contaminated Units , AABB
2013:
Performance characteristics of mass spectrometry for the rapid identification of cystic fibrosis pathogens in a regional USA laboratory practice , ECCMID
2013:
Dramatic Improvement in Accuracy and Time to Reporting When Identifying Cystic Fibrosis Pathogens: the Practical Impact of Mass Spectrometry, ASM
2013:
Real Time PCR Assay for the Identification of Bacterial Enteropathogens in Feces , ASM
2014:
Predominance of MRSA clonal complex (CC) 5 and CC8 from Human isolates in the Rural Wisconsin, ISSSI
2014:
Multicenter Evaluation of a New Isothermal Molecular GBS Assay: Comparison with Culture , ASM
2014:
Performance Characteristics of MALDI-TOF Mass Spectrometry Compared with 16S rDNA Sequencing for the Rapid Identification of Actinomyces spp. in a ‘One Health’ Laboratory Practice , ASM
2014:
Comparison Between Culture and a Helicase Dependent Amplification Method for the Detection of Group B Streptococcus , ECCMID
2015:
Head-to-Head Comparison between Commercially-Available MALDI-TOF Mass Spectrometry Systems for the Identification of Nontuberculous Mycobacteria, ASM
2015:
Validation of a Commercial Multiplex PCR for Rapid Detection of Respiratory Pathogens from Bronchial Specimens, ASM
2015:
Performance Characteristics of Mass Spectrometry Compared with Biochemical Approaches for the Rapid Identification of Corynebacterium spp. in a ‘One Health’ Laboratory Practice, ASM
2015:
Rapid and Cost-Effective Identification of Blood Culture Pathogens from 3-Hour Solid Media Growth Using Mass Spectrometry, ASM
2016:
‘One Health’ Laboratory Surveillance and Characterization of Multi-Drug Resistant Escherichia coli in the Upper USA Midwest: Preliminary Report, ECCMID
2016:
Benchmark Results and Trending Analysis Following Introduction of Nucleic Acid Tests for Diagnosis of Anaplasmosis, Ehrlichiosis and Babesiosis in Central and Northern Wisconsin (2013-2015), ASM
2017:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI Broth Microdilution Method for Debio 1452 (FAB) using non-Fastidious Gram-Positive Organisms, ASM Microbe
2017:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI Broth Microdilution Method for Omadacycline using non-Fastidious Gram-Positive Organisms, ASM Microbe
2017:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI Broth Microdilution Method for Delafloxacin using non-Fastidious Gram-Positive Organisms, ASM Microbe
2017:
Evidence for Clonotype Partitioning Among Multidrug-Resistant Escherichia coli Recovered from Human, Canine and Bovine Hosts: a ‘One Health’ Perspective, ASM Microbe
2017:
Low Clonal Overlap of Extended Spectrum ß-Lactamase-producing Escherichia coli from Human, Canine and Bovine Hosts in the Upper USA Midwest, ECCMID
2018:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI/ISO Broth Microdilution Method for Plazomicin using Non-Fastidious Gram-Negative Organisms, ASM Microbe
2018:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI/ISO Broth Microdilution Method for Eravacycline using Gram Positive and Gram Negative non-Fastidious Organisms, ASM Microbe
2018:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI/ISO Broth Microdilution Method for FDA Approved Delafloxacin (BAXDELA) using Fastidious Organisms, ASM Microbe
2018:
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI/ISO Broth Microdilution Method for FDA Approved Delafloxacin (BAXDELA) using Gram-Negative Non-Fastidious Organisms, ASM Microbe
2018:
Genomic Characterization of an NDM-Expressing Escherichia coli Isolate Recovered from a Canine Urinary Tract Infection in the USA Midwest, ECCMID